BlackRock Health Sciences Trust (BME) Fund Overview
BlackRock Health Sciences Trust (BME) — price $44.45 (-2.03%), as of the Nov 19, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
BlackRock Health Sciences Trust · BME
BlackRock Health Sciences Trust is a closed-end equity mutual fund managed by BlackRock Advisors, investing in health sciences and related sectors within the United States.
Price as of Nov 19, 2026
Key Statistics
Not scored: this is a debt/preferred or other non-common instrument, or its reported market value does not match its share basis.
Price & valuation
| Measure | Value |
|---|---|
| Latest provided price | $44.45 |
| Change on the day | -2.03% |
| Price / earnings (trailing) | 5.76 |
| Shares traded on the day | 44.3K |
Price & events
What is BlackRock Health Sciences Trust (BME), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. BlackRock Health Sciences Trust (BME) is the company analyzed here. In Q2 FY2026 it reported revenue of $31M and net income of $23M.
What do the latest results show for BlackRock Health Sciences Trust (BME)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $31M.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $31M | $23M | $1.82 (diluted) |
| Q4 FY2025 | $23M | $81M | $6.23 (diluted) |
| Q2 FY2025 | $4M | -$4M | -$0.28 (diluted) |
| Q4 FY2024 | $37M | -$22M | -$1.70 (diluted) |
What are the financial strengths and risks for BlackRock Health Sciences Trust (BME)?
Short answer · as of
The distress and quality screens read Piotroski F 4. Trailing ratios: ROE 18.3% · ROA 18.1% · earnings yield 16.8% · free-cash-flow yield -1.5%.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held BME in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported BME in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about BlackRock Health Sciences Trust (BME)?
Common Questions About BME
These answers are editorial: 1 of these 1 answer is drawn from the BME research dossier (written Mar 16, 2026 by gemini-2.0-flash). Figures in this section are not part of the source register.
What are the main risks for BME?
The main risks for BME include regulatory changes in the healthcare industry, which could negatively impact the profitability of healthcare companies. Market fluctuations could also affect the value of the fund's holdings. An economic downturn could impact healthcare spending and reduce demand for healthcare services.
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 10 figures on this page — 8 from Financial Modeling Prep (FMP) and 2 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com